Cargando…

Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer

Detalles Bibliográficos
Autores principales: Pang, Xiaocong, Sun, Xiaojiao, Gu, Yanlun, He, Xu, Gong, Kan, Song, Song, Zhang, Jixin, Xia, Jie, Liu, Zhenming, Cui, Yimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911763/
https://www.ncbi.nlm.nih.gov/pubmed/36759595
http://dx.doi.org/10.1038/s41392-022-01236-z
_version_ 1784885060441210880
author Pang, Xiaocong
Sun, Xiaojiao
Gu, Yanlun
He, Xu
Gong, Kan
Song, Song
Zhang, Jixin
Xia, Jie
Liu, Zhenming
Cui, Yimin
author_facet Pang, Xiaocong
Sun, Xiaojiao
Gu, Yanlun
He, Xu
Gong, Kan
Song, Song
Zhang, Jixin
Xia, Jie
Liu, Zhenming
Cui, Yimin
author_sort Pang, Xiaocong
collection PubMed
description
format Online
Article
Text
id pubmed-9911763
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-99117632023-02-11 Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer Pang, Xiaocong Sun, Xiaojiao Gu, Yanlun He, Xu Gong, Kan Song, Song Zhang, Jixin Xia, Jie Liu, Zhenming Cui, Yimin Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-02-10 /pmc/articles/PMC9911763/ /pubmed/36759595 http://dx.doi.org/10.1038/s41392-022-01236-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Pang, Xiaocong
Sun, Xiaojiao
Gu, Yanlun
He, Xu
Gong, Kan
Song, Song
Zhang, Jixin
Xia, Jie
Liu, Zhenming
Cui, Yimin
Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer
title Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer
title_full Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer
title_fullStr Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer
title_full_unstemmed Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer
title_short Discovery of C19-9 as a novel non-RGD inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer
title_sort discovery of c19-9 as a novel non-rgd inhibitor of αvβ3 to overcome enzalutamide resistance in castration-resistant prostate cancer
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911763/
https://www.ncbi.nlm.nih.gov/pubmed/36759595
http://dx.doi.org/10.1038/s41392-022-01236-z
work_keys_str_mv AT pangxiaocong discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer
AT sunxiaojiao discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer
AT guyanlun discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer
AT hexu discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer
AT gongkan discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer
AT songsong discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer
AT zhangjixin discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer
AT xiajie discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer
AT liuzhenming discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer
AT cuiyimin discoveryofc199asanovelnonrgdinhibitorofavb3toovercomeenzalutamideresistanceincastrationresistantprostatecancer